Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 94 articles:
HTML format



Single Articles


    May 2022
  1. ROSENBLUM HG, Lewis RM, Gargano JW, Querec TD, et al
    Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018.
    Ann Intern Med. 2022 May 17. doi: 10.7326/M21-3798.
    PubMed     Abstract available


  2. PERKINS RB, Saslow D, Oliver K
    Long-Term Effectiveness of Human Papillomavirus Vaccination: Implications for Future Reduction in Cancer.
    Ann Intern Med. 2022 May 17. doi: 10.7326/M22-1309.
    PubMed    


  3. ASSOUMOU SA, Peterson A, Ginman E, James T, et al
    Addressing Inequities in SARS-CoV-2 Vaccine Uptake: The Boston Medical Center Health System Experience.
    Ann Intern Med. 2022 May 17. doi: 10.7326/M22-0028.
    PubMed     Abstract available


  4. KRYCHTIUK KA, Newby LK
    Moderna COVID-19 vaccine was linked to myocarditis or myopericarditis at 28 d (4.2 events/100 000 persons).
    Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0021.
    PubMed     Abstract available


  5. GRANWEHR BP
    In adults who had not had COVID-19, Novavax vaccine had 90% efficacy at >/=7 d after the second dose.
    Ann Intern Med. 2022 May 3. doi: 10.7326/J22-0028.
    PubMed     Abstract available


  6. ZAHRADKA I, Petr V, Modos I, Magicova M, et al
    Association Between SARS-CoV-2 Messenger RNA Vaccines and Lower Infection Rates in Kidney Transplant Recipients : A Registry-Based Report.
    Ann Intern Med. 2022 May 3. doi: 10.7326/M21-2973.
    PubMed     Abstract available


    April 2022
  7. KOTTON CN
    Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of COVID-19 in Immunocompromised Patients.
    Ann Intern Med. 2022 Apr 12. doi: 10.7326/M22-1026.
    PubMed    


  8. ROTHBERG MB
    Community-Acquired Pneumonia.
    Ann Intern Med. 2022 Apr 12. doi: 10.7326/AITC202204190.
    PubMed     Abstract available


    March 2022
  9. ZHENG C, Duffy J, Liu IA, Sy LS, et al
    Risk for Shoulder Conditions After Vaccination: A Population-Based Study Using Real-World Data.
    Ann Intern Med. 2022 Mar 22. doi: 10.7326/M21-3023.
    PubMed     Abstract available


  10. LARSON EB, Nelson JC
    In older adults, use of a recombinant zoster vaccine was associated with Guillain-Barre syndrome.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0010.
    PubMed     Abstract available


  11. SILVESTRI EG, Borzak S
    In patients with MI or high-risk coronary disease, influenza vaccination reduced CV events at 12 mo.
    Ann Intern Med. 2022 Mar 1. doi: 10.7326/J22-0006.
    PubMed     Abstract available


    February 2022
  12. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine : A Retrospective Cohort Study.
    Ann Intern Med. 2022 Feb 15. doi: 10.7326/M21-4130.
    PubMed     Abstract available


  13. HVIID A, Hansen JV, Thiesson EM, Wohlfahrt J, et al
    Association of AZD1222 and BNT162b2 COVID-19 Vaccination With Thromboembolic and Thrombocytopenic Events in Frontline Personnel : A Retrospective Cohort Study.
    Ann Intern Med. 2022 Feb 1. doi: 10.7326/M21-2452.
    PubMed     Abstract available


  14. KANG M, Yi Y, Li Y, Sun L, et al
    Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China : A Cohort Study.
    Ann Intern Med. 2022 Feb 1. doi: 10.7326/M21-3509.
    PubMed     Abstract available


  15. CHANG R
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Another Way That Hospitalists Can Fight COVID-19.
    Ann Intern Med. 2022;175:HO2-HO3.
    PubMed    


    January 2022
  16. TSUN LAI FT, Li X, Peng K, Huang L, et al
    Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.
    Ann Intern Med. 2022 Jan 25. doi: 10.7326/M21-3700.
    PubMed     Abstract available


  17. QASEEM A, Yost J, Etxeandia-Ikobaltzeta I, Forciea MA, et al
    What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 Infection? Rapid, Living Practice Points From the American College of Physicians (Version 2).
    Ann Intern Med. 2022 Jan 25. doi: 10.7326/M21-3272.
    PubMed     Abstract available


  18. SEE I, Lale A, Marquez P, Streiff MB, et al
    Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination-United States, December 2020 to August 2021.
    Ann Intern Med. 2022 Jan 18. doi: 10.7326/M21-4502.
    PubMed     Abstract available


  19. CAILLARD S, Thaunat O, Benotmane I, Masset C, et al
    Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series.
    Ann Intern Med. 2022 Jan 11. doi: 10.7326/L21-0598.
    PubMed    


    December 2021
  20. IOANNOU GN, Locke ER, O'Hare AM, Bohnert ASB, et al
    COVID-19 Vaccination Effectiveness Against Infection or Death in a National U.S. Health Care System : A Target Trial Emulation Study.
    Ann Intern Med. 2021 Dec 21. doi: 10.7326/M21-3256.
    PubMed     Abstract available


  21. FAY MP, Hunsberger S, Follmann D
    Risk Heterogeneity and the Illusion of Waning Vaccine Efficacy.
    Ann Intern Med. 2021 Dec 21. doi: 10.7326/M21-3609.
    PubMed    


  22. ANAND S, Montez-Rath ME, Han J, Garcia P, et al
    SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis.
    Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-4176.
    PubMed     Abstract available


  23. LAINE C, Moyer DV, Cotton D
    COVID-19: Challenging Clinical Questions.
    Ann Intern Med. 2021 Dec 14. doi: 10.7326/M21-4611.
    PubMed    



  24. Correction: Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
    Ann Intern Med. 2021;174:1780.
    PubMed    


    November 2021
  25. KUMAR D, Ferreira VH, Hall VG, Hu Q, et al
    Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine : Secondary Analysis of a Randomized Trial.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-3480.
    PubMed     Abstract available


  26. CHO BH, Weinbaum C, Tsai Y, Koppaka R, et al
    Influenza Vaccine Uptake and Missed Opportunities Among the Medicare-Covered Population With High-Risk Conditions During the 2018 to 2019 Influenza Season : A Retrospective Cohort Study.
    Ann Intern Med. 2021 Nov 16. doi: 10.7326/M21-1550.
    PubMed     Abstract available


  27. SARPATWARI A, Pandya A, Hyle EP, Persad G, et al
    COVID-19 Vaccine Boosters for All Adults: An Optimal U.S. Approach?
    Ann Intern Med. 2021 Nov 9. doi: 10.7326/M21-3927.
    PubMed    


  28. UYEKI TM
    Influenza.
    Ann Intern Med. 2021 Nov 9. doi: 10.7326/AITC202111160.
    PubMed     Abstract available


  29. MAKI DG
    Recommendations were made for diagnosis and management of allergic reactions to COVID-19 vaccines.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  30. GRANWEHR BP
    BioNTech/Pfizer vaccine after Oxford/AZ vaccine increased immune response vs. no second vaccine.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  31. SACKS HS
    The Novavax vaccine had 90% efficacy against COVID-19 >/=7 d after the second dose.
    Ann Intern Med. 2021 Nov 2. doi: 10.7326/ACPJ202111160.
    PubMed     Abstract available


  32. DORFMAN AL, Murthy VL
    Web Exclusive. Annals for Hospitalists Inpatient Notes - Myocarditis After Vaccination for SARS-CoV-2.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed    


    October 2021
  33. HIMMELSTEIN J, Himmelstein DU, Woolhandler S, Dickman S, et al
    COVID-19-Related Care for Hispanic Elderly Adults With Limited English Proficiency.
    Ann Intern Med. 2021 Oct 26. doi: 10.7326/M21-2900.
    PubMed    


  34. NOVAZZI F, Taborelli S, Baj A, Focosi D, et al
    Asymptomatic SARS-CoV-2 Vaccine Breakthrough Infections in Health Care Workers Identified Through Routine Universal Surveillance Testing.
    Ann Intern Med. 2021 Oct 19. doi: 10.7326/M21-3486.
    PubMed    


  35. MELMED GY, Botwin GJ, Sobhani K, Li D, et al
    Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2483.
    PubMed    


  36. LAINE C, Cotton D, Moyer DV
    COVID-19: Clinical and Public Health Implications of SARS-CoV-2 Immunology.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-3840.
    PubMed    


  37. DELANEY SW, Essien UR, Navathe A
    Disparate Impact: How Colorblind Policies Exacerbate Black-White Health Inequities.
    Ann Intern Med. 2021;174:1450-1451.
    PubMed    


    September 2021
  38. CURTIS JR, Cofield SS, Bridges SL Jr, Bassler J, et al
    The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M20-6928.
    PubMed     Abstract available


  39. REIF J, Heun-Johnson H, Tysinger B, Lakdawalla D, et al
    Measuring the COVID-19 Mortality Burden in the United States : A Microsimulation Study.
    Ann Intern Med. 2021 Sep 21. doi: 10.7326/M21-2239.
    PubMed     Abstract available


  40. AL-SAMKARI H, Leaf RK, Goodarzi K
    Transient Thrombocytopenia With Glycoprotein-Specific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/L21-0427.
    PubMed    


  41. MOGHADAS SM, Sah P, Shoukat A, Meyers LA, et al
    Population Immunity Against COVID-19 in the United States.
    Ann Intern Med. 2021 Sep 14. doi: 10.7326/M21-2721.
    PubMed     Abstract available


    August 2021
  42. DEEPAK P, Kim W, Paley MA, Yang M, et al
    Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2 : A Prospective Cohort Study.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-1757.
    PubMed     Abstract available


  43. PALTIEL AD, Schwartz JL
    Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021.
    Ann Intern Med. 2021 Aug 31. doi: 10.7326/M21-2965.
    PubMed     Abstract available


  44. CENTOR RM, Klompas M, Pearson M, Morris C, et al
    Annals On Call - The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Aug 10:OC1. doi: 10.7326/A20-0020.
    PubMed    


    July 2021
  45. EMANUEL EJ, Skorton DJ
    Mandating COVID-19 Vaccination for Health Care Workers.
    Ann Intern Med. 2021 Jul 30. doi: 10.7326/M21-3150.
    PubMed    


  46. BUTT AA, Omer SB, Yan P, Shaikh OS, et al
    SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting.
    Ann Intern Med. 2021 Jul 20. doi: 10.7326/M21-1577.
    PubMed     Abstract available


  47. KLOMPAS M, Pearson M, Morris C
    The Case for Mandating COVID-19 Vaccines for Health Care Workers.
    Ann Intern Med. 2021 Jul 13. doi: 10.7326/M21-2366.
    PubMed    


  48. SACKS HS
    The single-dose J&J vaccine had 67% efficacy against moderate to severe-critical COVID-19 at >/=14 d.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available


    June 2021
  49. SANGLI S, Virani A, Cheronis N, Vannatter B, et al
    Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/L21-0244.
    PubMed    


  50. LAVANGE L, Adam SJ, Currier JS, Higgs ES, et al
    Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 Therapeutics.
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-1269.
    PubMed     Abstract available


  51. PISHKO AM, Cuker A
    Thrombosis After Vaccination With Messenger RNA-1273: Is This Vaccine-Induced Thrombosis and Thrombocytopenia or Thrombosis With Thrombocytopenia Syndrome?
    Ann Intern Med. 2021 Jun 29. doi: 10.7326/M21-2680.
    PubMed    


  52. THORNTON JD, Dixon-Williams S, Huml A, Perzynski A, et al
    A Cross-Sectional Study of SARS-CoV-2 Vaccination Among Employees of an Urban Safety-Net Health Care System.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/M21-1513.
    PubMed    


  53. MATHENY M, Maleque N, Channell N, Eisch AR, et al
    Severe Exacerbations of Systemic Capillary Leak Syndrome After COVID-19 Vaccination: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0250.
    PubMed    


  54. WERBEL WA, Boyarsky BJ, Ou MT, Massie AB, et al
    Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.
    Ann Intern Med. 2021 Jun 15. doi: 10.7326/L21-0282.
    PubMed    


  55. BILINSKI A, Salomon JA, Giardina J, Ciaranello A, et al
    Passing the Test: A Model-Based Analysis of Safe School-Reopening Strategies.
    Ann Intern Med. 2021 Jun 8. doi: 10.7326/M21-0600.
    PubMed     Abstract available


    May 2021
  56. CONNOLLY CM, Boyarsky BJ, Ruddy JA, Werbel WA, et al
    Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1451.
    PubMed    


  57. MARION O, Del Bello A, Abravanel F, Couat C, et al
    Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1341.
    PubMed    


  58. ARNOLD DT, Milne A, Samms E, Stadon L, et al
    Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series.
    Ann Intern Med. 2021 May 25. doi: 10.7326/M21-1976.
    PubMed    


  59. IRFAN N, Chagla Z
    In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B.1.351 variant).
    Ann Intern Med. 2021 May 4. doi: 10.7326/ACPJ202105180.
    PubMed     Abstract available


    April 2021

  60. Correction: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Apr 20. doi: 10.7326/L21-0233.
    PubMed    


  61. FOLLMANN D, Fintzi J, Fay MP, Janes HE, et al
    A Deferred-Vaccination Design to Assess Durability of COVID-19 Vaccine Effect After the Placebo Group Is Vaccinated.
    Ann Intern Med. 2021 Apr 13. doi: 10.7326/M20-8149.
    PubMed     Abstract available


  62. MUSTAFA SS, Ramsey A, Staicu ML
    Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.
    Ann Intern Med. 2021 Apr 6. doi: 10.7326/L21-0104.
    PubMed    


    March 2021
  63. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Practical Clinical Considerations.
    Ann Intern Med. 2021 Mar 26. doi: 10.7326/M21-1260.
    PubMed    


  64. TROGEN B, Caplan A
    Risk Compensation and COVID-19 Vaccines.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/M20-8251.
    PubMed    


  65. CHAGLA Z
    In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19 >/=14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  66. CHAGLA Z
    In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19 >14 d after the 2nd dose.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  67. FREEDMAN MS, Bernstein H, Ault KA
    Recommended Adult Immunization Schedule, United States, 2021.
    Ann Intern Med. 2021;174:374-384.
    PubMed    


    February 2021
  68. CENTOR RM, Riley LE
    Annals On Call - Pregnancy, Lactation, and the COVID-19 Vaccines.
    Ann Intern Med. 2021 Feb 23:OC1. doi: 10.7326/A20-0009.
    PubMed    


  69. SALISCH NC, Stephenson KE, Williams K, Cox F, et al
    A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti-Zika Virus Vaccine.
    Ann Intern Med. 2021 Feb 16. doi: 10.7326/M20-5306.
    PubMed     Abstract available


  70. OPEL DJ, Lo B, Peek ME
    Addressing Mistrust About COVID-19 Vaccines Among Patients of Color.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M21-0055.
    PubMed    


  71. GADOTH A, Halbrook M, Martin-Blais R, Gray A, et al
    Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles.
    Ann Intern Med. 2021 Feb 9. doi: 10.7326/M20-7580.
    PubMed    


  72. TROTTER AB, Abbott EK, Coyle R, Shen AK, et al
    Preparing for COVID-19 Vaccination: A Call to Action for Clinicians on Immunization Information Systems.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/M20-7725.
    PubMed    


  73. CHAGLA Z
    The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >/=7 days after the 2nd dose.
    Ann Intern Med. 2021 Feb 2. doi: 10.7326/ACPJ202102160.
    PubMed     Abstract available


    January 2021
  74. RILEY LE, Jamieson DJ
    Inclusion of Pregnant and Lactating Persons in COVID-19 Vaccination Efforts.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0173.
    PubMed    


  75. FARRIS GE
    Annals Graphic Medicine - Dr. Mom: The Emotions of Getting the COVID-19 Vaccine.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/G20-0119.
    PubMed    


  76. GREGORY JM, Moore DJ
    The Dual Burden of Type 1 Diabetes and COVID-19.
    Ann Intern Med. 2021 Jan 26. doi: 10.7326/M21-0367.
    PubMed    


  77. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Ann Intern Med. 2021 Jan 25. doi: 10.7326/M21-0331.
    PubMed    


  78. CONNORS M, Graham BS, Lane HC, Fauci AS, et al
    SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.
    Ann Intern Med. 2021 Jan 19. doi: 10.7326/M21-0111.
    PubMed    


  79. CENTOR RM, Manning KD
    Annals On Call - Vaccine Hesitancy: Choosing Our Battles.
    Ann Intern Med. 2021 Jan 19:OC1. doi: 10.7326/A20-0006.
    PubMed    


  80. PALTIEL AD, Zheng A, Schwartz JL
    Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-7866.
    PubMed    


  81. CARRERA M, Lawler EC, White C
    Population Mortality and Laws Encouraging Influenza Vaccination for Hospital Workers.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-0413.
    PubMed     Abstract available


  82. BARNABAS RV, Wald A
    A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8060.
    PubMed    


  83. BOLLYKY TJ
    U.S. COVID-19 Vaccination Challenges Go Beyond Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8280.
    PubMed    


  84. TUITE AR, Zhu L, Fisman DN, Salomon JA, et al
    Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/M20-8137.
    PubMed    


    December 2020
  85. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: Promoting Vaccine Acceptance.
    Ann Intern Med. 2020 Dec 21. doi: 10.7326/M20-8008.
    PubMed    


  86. PALMER T, Cuschieri K
    Human Papillomavirus Immunization and the Elimination of Cervical Carcinoma.
    Ann Intern Med. 2020;173:935-936.
    PubMed    


    November 2020
  87. CENTOR RM, Goepfert P
    Annals On Call - A Primer on COVID-19 Vaccines.
    Ann Intern Med. 2020 Nov 24:OC1. doi: 10.7326/A19-0044.
    PubMed    


  88. MACPHERSON A, Hutchinson N, Schneider O, Oliviero E, et al
    Probability of Success and Timelines for the Development of Vaccines for Emerging and Reemerged Viral Infectious Diseases.
    Ann Intern Med. 2020 Nov 24. doi: 10.7326/M20-5350.
    PubMed     Abstract available


  89. DAL-RE R, Caplan AL, Gluud C, Porcher R, et al
    Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Ann Intern Med. 2020 Nov 20. doi: 10.7326/M20-7357.
    PubMed    


    October 2020
  90. MEHROTRA DV, Janes HE, Fleming TR, Annunziato PW, et al
    Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials.
    Ann Intern Med. 2020 Oct 22. doi: 10.7326/M20-6169.
    PubMed     Abstract available


  91. LAINE C, Cotton D, Moyer DV
    COVID-19 Vaccine: What Physicians Need to Know.
    Ann Intern Med. 2020 Oct 20. doi: 10.7326/M20-6841.
    PubMed    


    September 2020
  92. BAUSSANO I, Tshomo U, Tenet V, Heideman DAM, et al
    Prevalence of Human Papillomavirus and Estimation of Human Papillomavirus Vaccine Effectiveness in Thimphu, Bhutan, in 2011-2012 and 2018 : A Cross-sectional Study.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-2849.
    PubMed     Abstract available


  93. LUDVIGSSON JF, Winell H, Sandin S, Cnattingius S, et al
    Maternal Influenza A(H1N1) Immunization During Pregnancy and Risk for Autism Spectrum Disorder in Offspring : A Cohort Study.
    Ann Intern Med. 2020 Sep 1. doi: 10.7326/M20-0167.
    PubMed     Abstract available


    August 2020
  94. CHOW EJ, Rolfes MA, O'Halloran A, Anderson EJ, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults : A Cross-sectional Study.
    Ann Intern Med. 2020 Aug 25. doi: 10.7326/M20-1509.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: